Lumify
Marketedupdated 2mo agoby $BLCO Bausch & Lomb Corp
Approvedcommunity read0 votes
Small molecule drug with a maximum clinical stage of Approval (across all indications), with 7 approved and 9 investigational indications.
all catalysts(13)
approval · 13
May 22, 2006
approval
QOLIANA (BRIMONIDINE TARTRATE) — FDA approval
Lumify
→
Oct 30, 2007
approval
COMBIGAN (BRIMONIDINE TARTRATE) — FDA approval
Lumify
→
Aug 3, 2010
approval
QOLIANA (BRIMONIDINE TARTRATE) — FDA approval
Lumify
→
Mar 27, 2012
approval
QOLIANA (BRIMONIDINE TARTRATE) — FDA approval
Lumify
→
Oct 11, 2012
approval
COMBIGAN (BRIMONIDINE TARTRATE) — FDA approval
Lumify
→
Sep 25, 2014
approval
QOLIANA (BRIMONIDINE TARTRATE) — FDA approval
Lumify
→
Oct 15, 2015
approval
COMBIGAN (BRIMONIDINE TARTRATE) — FDA approval
Lumify
→
Nov 10, 2015
approval
QOLIANA (BRIMONIDINE TARTRATE) — FDA approval
Lumify
→
Jan 19, 2016
approval
QOLIANA (BRIMONIDINE TARTRATE) — FDA approval
Lumify
→
Nov 21, 2025
approval
QOLIANA (BRIMONIDINE TARTRATE) — FDA approval
Lumify
→
Mar 11, 2026
approval
BRIMONIDINE TARTRATE — FDA approval
Lumify
→
Mar 17, 2026
approval
COMBIGAN (BRIMONIDINE TARTRATE) — FDA approval
Lumify
→
Apr 16, 2026
approval
BRIMONIDINE TARTRATE — FDA approval
Lumify
→
News(0)
no news has mentioned this drug yet
comments(0)
5-min edit window · permanent after that